Intestinal protozoan infections in the immunocompromised host

Area of Science:

• Medical Microbiology
• Immunology
• Infectious Diseases

Background:

• Intestinal protozoa are increasingly identified as critical pathogens in immunocompromised individuals.
• The pathogenesis, diagnosis, and management of these infections remain significant challenges.

Purpose of the Study:

• To review the current understanding of intestinal protozoan infections in immunocompromised hosts.
• To highlight challenges in diagnosis and treatment and suggest future research directions.

Main Methods:

• Review of recent findings on intestinal protozoa in immunocompromised patients.
• Discussion of diagnostic advancements, including molecular assays like PCR.
• Analysis of treatment strategies, emphasizing immune modulation and antiparasitic therapy.

Main Results:

• Impaired T-cell immunity facilitates protozoan invasion, with HIV and transplant patients at highest risk.
• Cryptosporidium, Cyclospora, and Isospora are common, with Microsporidia and Blastocystis emerging.
• No new effective drugs reported; reducing immunosuppression combined with antiparasitic therapy is most effective.

Conclusions:

• Pathogenesis in immunosuppression is poorly understood, with limited therapeutic development.
• Improved PCR-based detection aids management and epidemiological understanding.
• Early detection and effective treatment are crucial for favorable outcomes; further research into pathogenesis is needed.